Disease and Immune related mRNAs
-
R1020 EZ Cap™ EPO mRNA (ψUTP)2 CitationSummary: Human erythropoietin (EPO) mRNA with Cap 1 structure, modified by ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation. -
R1028 EZ Cap™ OVA mRNA (5-moUTP)1 CitationSummary: Ovalbumin mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation -
R2011 Human p53 circRNASummary: Circular RNA expressing human p53 protein -
R1057 EZ Cap™ Human IL-12 mRNA (m1Ψ,HA tag)Summary: Human IL-12 mRNA with Cap 1 structure and HA tag sequence., modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1058 EZ Cap™ Mouse IL-12 mRNA (m1Ψ)Summary: Mouse IL-12 mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1049 EZ Cap™ Mouse IFN-γ mRNA (5mCTP, ψUTP)Summary: Mouse IFN-γ mRNA with Cap 1 structure, modified by 5mCTP and ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation -
R1050 EZ Cap™ Mouse IFN-α mRNA (m1ψ)Summary: Mouse IFN-α mRNA with Cap 1 structure, modified by m1ψ, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation -
R1054 EZ Cap™ Mouse IL-7 mRNA (m1Ψ, HA tag)Summary: Mouse IL-7 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1059 EZ Cap™ Mouse IL-12 mRNA (m1Ψ, HA tag)Summary: Mouse IL-12 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. -
R1063 EZ Cap™ Human IL-21 mRNA (m1Ψ, HA tag)Summary: Human IL-21 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

